Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $731.06M.
ENTERPRISE VALUE (EV)
$731.06M
Achieve Life Sciences, Inc.
Market Cap
$737.09M
Enterprise Value (EV)
$731.06M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Achieve Life Sciences, Inc. (ACHV) | $737.09M | $731.06M |
| Faeth Therapeutics, Inc. (FTH)vs › | $737.40M | $711.09M |
| Candel Therapeutics, Inc. (CADL)vs › | $744.71M | $592.66M |
| Cytek Biosciences, Inc. (CTKB)vs › | $720.94M | $673.55M |
| Avalo Therapeutics, Inc. (AVTX)vs › | $719.59M | $634.45M |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $717.44M | $1.45B |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $714.33M | $666.39M |
| Design Therapeutics, Inc. (DSGN)vs › | $759.48M | $748.60M |
| Mesa Laboratories, Inc. (MLAB)vs › | $771.14M | $841.80M |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $779.56M | $797.92M |
Market Cap
$737.09M
Total Debt
$14.89M
Cash
$20.93M
Enterprise Value
$731.06M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
